Lifecome Biochemistry Co.,Ltd.

Shenzhen Stock Exchange 002868.SZ

Lifecome Biochemistry Co.,Ltd. Revenue for the year ending December 31, 2023: USD 71.41 M

Lifecome Biochemistry Co.,Ltd. Revenue is USD 71.41 M for the year ending December 31, 2023, a 49.40% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Lifecome Biochemistry Co.,Ltd. Revenue for the year ending December 31, 2022 was USD 47.80 M, a -16.42% change year over year.
Lifecome Biochemistry Co.,Ltd. Revenue for the year ending December 31, 2021 was USD 57.19 M, a 21.14% change year over year.
Lifecome Biochemistry Co.,Ltd. Revenue for the year ending December 31, 2020 was USD 47.21 M, a 8.23% change year over year.
Lifecome Biochemistry Co.,Ltd. Revenue for the year ending December 31, 2019 was USD 43.62 M, a -12.86% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Shenzhen Stock Exchange: 002868.SZ

Lifecome Biochemistry Co.,Ltd.

CEO	Mr. Zhongshou Bao
IPO Date	May 3, 2017
Location	China
Headquarters	No. 19,Nanpu Ecological Industrial Park
Employees	992
Sector	Consumers Staples
Industries Personal Care Biotechnology Cleaning Supplies Cosmetics Fertilizers Pet Food Pharmaceuticals Plastics

Description

Lifecome Biochemistry Co.,Ltd. operates as a biopharmaceutical company in China. It primarily offers bacitracin zinc products, colistin sulfate products, probiotics products, bacitracin methylene disalicylate products, biological preservatives, natamycin products, etc. The company was founded in 2003 and is based in Pucheng, China.

Key trends

Past 5 years